The journey to understanding incretin systems: Theory, practice and more theory

Accumulating clinical data on incretin‐based dipeptidyl peptidase‐4 inhibitors and glucagon‐like peptide‐1 receptor agonists in the past decade have clearly confirmed their safety and efficacy as antidiabetes drugs. However, the journey to understand the incretin system and its role in health and di...

Descripción completa

Detalles Bibliográficos
Autores principales: Yabe, Daisuke, Kuwata, Hitoshi, Seino, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
JDI Updates
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717807/
https://www.ncbi.nlm.nih.gov/pubmed/31361402
http://dx.doi.org/10.1111/jdi.13123
_version_ 1783447616209551360
author Yabe, Daisuke
Kuwata, Hitoshi
Seino, Yutaka
author_facet Yabe, Daisuke
Kuwata, Hitoshi
Seino, Yutaka
author_sort Yabe, Daisuke
collection PubMed
description Accumulating clinical data on incretin‐based dipeptidyl peptidase‐4 inhibitors and glucagon‐like peptide‐1 receptor agonists in the past decade have clearly confirmed their safety and efficacy as antidiabetes drugs. However, the journey to understand the incretin system and its role in health and disease continues.[Image: see text]
format Online
Article
Text
id pubmed-6717807
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-67178072019-09-06 The journey to understanding incretin systems: Theory, practice and more theory Yabe, Daisuke Kuwata, Hitoshi Seino, Yutaka J Diabetes Investig JDI Updates Accumulating clinical data on incretin‐based dipeptidyl peptidase‐4 inhibitors and glucagon‐like peptide‐1 receptor agonists in the past decade have clearly confirmed their safety and efficacy as antidiabetes drugs. However, the journey to understand the incretin system and its role in health and disease continues.[Image: see text] John Wiley and Sons Inc. 2019-08-20 2019-09 /pmc/articles/PMC6717807/ /pubmed/31361402 http://dx.doi.org/10.1111/jdi.13123 Text en © 2019 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle JDI Updates
Yabe, Daisuke
Kuwata, Hitoshi
Seino, Yutaka
The journey to understanding incretin systems: Theory, practice and more theory
title The journey to understanding incretin systems: Theory, practice and more theory
title_full The journey to understanding incretin systems: Theory, practice and more theory
title_fullStr The journey to understanding incretin systems: Theory, practice and more theory
title_full_unstemmed The journey to understanding incretin systems: Theory, practice and more theory
title_short The journey to understanding incretin systems: Theory, practice and more theory
title_sort journey to understanding incretin systems: theory, practice and more theory
topic JDI Updates
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717807/
https://www.ncbi.nlm.nih.gov/pubmed/31361402
http://dx.doi.org/10.1111/jdi.13123
work_keys_str_mv AT yabedaisuke thejourneytounderstandingincretinsystemstheorypracticeandmoretheory
AT kuwatahitoshi thejourneytounderstandingincretinsystemstheorypracticeandmoretheory
AT seinoyutaka thejourneytounderstandingincretinsystemstheorypracticeandmoretheory
AT yabedaisuke journeytounderstandingincretinsystemstheorypracticeandmoretheory
AT kuwatahitoshi journeytounderstandingincretinsystemstheorypracticeandmoretheory
AT seinoyutaka journeytounderstandingincretinsystemstheorypracticeandmoretheory

Ejemplares similares